Net Income

The chipmaker topped Q1 estimates and eyes a strong Q2, fueled by EV and AI markets, even as restructuring charges weigh on its bottom line.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

The private energy giant posted $171M in free cash flow, cut debt, and earned a Fitch upgrade, signaling robust health amid market volatility.

Rogers Corporation adds two powerhouse CEOs to its board, signaling a strategic push to dominate high-growth markets like EVs and advanced industrial tech.

The agricultural lender posted a $294M net income, navigating economic forecasts with strong credit quality and strategic investments in technology and talent.

OSG's new platform aims to slash costs and automate tedious tasks for property and HOA managers, tackling the industry's 'do more with less' challenge.

A new AI-powered technology can spot deadly high potassium levels using a simple smartwatch ECG, a breakthrough that could transform remote patient care.

With its new CCO, the AI health-tech firm aims to commercialize its patient-data platform, tackling billion-dollar delays in drug development.

With key clinical data on the horizon for its cancer and ALS drugs, LeonaBio adds deep financial, operational, and strategic expertise to its leadership.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

A new report reveals passkey adoption is surging globally. With 90% awareness, is the age of the password finally coming to an end for good?

Warner Bros. Discovery unveils a massive 30th-anniversary campaign for Space Jam, blending nostalgia with a modern, multi-platform business strategy.

ESR secures its fourth consecutive Red Dot Design Award, proving that innovative accessories are essential tools for today's flexible work and study life.

Phoenix-based DarkPulse gets exclusive rights to the Navy's cutting-edge laser targeting tech, but can the firm overcome financial hurdles to succeed?

A new partnership between Health Impact Alliance and Infineon promises to keep seniors independent longer using advanced chips, Wi-Fi 6, and edge AI.

A five-year exclusive deal for MilliporeSigma to test Genetix's gene therapies is set to ensure safety and expand access to one-time cures for rare diseases.

A new strategic partnership aims to slash preclinical failure rates by integrating advanced AI modeling directly into early-phase drug trials.

A leading scientific body is ditching 'longevity' for 'geroscience,' aiming to bring scientific rigor to a field rife with hype and misinformation.

Chicago Atlantic posts stable Q1 distributable earnings but a sharp drop in net income due to credit provisions, banking on a cannabis rescheduling windfall.